SKI Market

A+| A| A-|

Indian Indices

Sensex

75,183.36 -135.03
( -0.18%)

Global Indices

Nasdaq

50,311.43 281.08
(0.56%)

Dow Jones

7,466.66 12.69
(0.17%)

Hang Seng

61,747.25 1,942.84
(3.25%)

Nikkei 225

10,466.07 33.73
(0.32%)

Forex

USD-INR

96.52 0.30
(0.32%)

EUR-INR

112.16 0.19
(0.17%)

GBP-INR

129.37 0.68
(0.52%)

JPY-INR

0.61 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

423.385578

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

30.6

113225.36

EPS(TTM)

Face Value()

Div & Yield %

45.81

0.93

Back

Conart Engineers standalone net profit rises 258.33% in the September 2025 quarter

Nov 15,2025

Net profit of Conart Engineers rose 258.33% to Rs 1.29 crore in the quarter ended September 2025 as against Rs 0.36 crore during the previous quarter ended September 2024. Sales rose 53.55% to Rs 16.23 crore in the quarter ended September 2025 as against Rs 10.57 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	16.23	10.57	54
OPM %	9.18	2.46	-
PBDT	1.90	0.31	513
PBT	1.72	0.17	912
NP	1.29	0.36	258

75,183.36 -135.03 ( -0.18%)

50,311.43 281.08 (0.56%)

7,466.66 12.69 (0.17%)

61,747.25 1,942.84 (3.25%)

10,466.07 33.73 (0.32%)

96.52 0.30 (0.32%)

112.16 0.19 (0.17%)

129.37 0.68 (0.52%)

0.61 0.00 (0.22%)